PacBio's HiFi Sequencing Identifies Genetic Causes in 10% of Unexplained Subfertility Cases

  • PacBio's HiFi long-read sequencing identified clinically relevant genomic findings in ~10% of couples with unexplained subfertility in a multicenter study across Asia-Pacific.
  • The study involved 96 individuals (47 couples and 2 individuals) across five institutions in Singapore, South Korea, Thailand, and Taiwan.
  • HiFi sequencing enabled comprehensive analysis of multiple forms of genomic variation in a single assay, reducing the need for sequential testing.
  • The consortium used DNAstack’s federated analysis framework to harmonize data across countries and institutions.
  • PacBio plans to expand recruitment and evaluate broader multi-omic approaches to improve accessibility and cost-efficiency.

PacBio's study highlights the potential of long-read sequencing to resolve complex reproductive genetic cases that remain unexplained using conventional testing. The collaborative framework of the HiFi Solves Sub-fertility Consortium in Asia-Pacific demonstrates the importance of multi-center efforts in advancing reproductive genomics. This study could pave the way for more comprehensive and efficient genetic evaluations in subfertility, potentially reducing the time and cost associated with sequential testing.

Diagnostic Yield
How the 10% diagnostic yield from HiFi sequencing will scale with larger, more diverse patient populations.
Cost Efficiency
Whether PacBio's scalable workflows, such as SPRQ-Nx, can reduce the cost of reproductive genomics studies.
Regulatory Adoption
The pace at which HiFi sequencing could be adopted as a first-line genomic test for subfertility.